Yahoo
OTC Markets OTCQX - Delayed Quote USD

BioLargo, Inc. (BLGO)

0.0920 -0.0030 (-3.16%)
As of 9:31:47 AM EDT. Market Open.
Chart Range Bar
Loading chart for BLGO
  • Previous Close 0.0950
  • Open 0.0950
  • Bid 0.0920 x 2000000
  • Ask 0.0939 x 48607900
  • Day's Range 0.0920 - 0.0950
  • 52 Week Range 0.0800 - 0.2300
  • Volume 75,000
  • Avg. Volume 374,722
  • Market Cap (intraday) 30.243M
  • Beta (5Y Monthly) -0.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 28, 1997
  • 1y Target Est 0.30

BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.

www.biolargo.com

44

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 9/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BLGO
48.89%
S&P 500 (^GSPC)
12.71%

1-Year Return

BLGO
60.00%
S&P 500 (^GSPC)
19.65%

3-Year Return

BLGO
45.88%
S&P 500 (^GSPC)
70.85%

5-Year Return

BLGO
51.58%
S&P 500 (^GSPC)
70.11%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 1.11M
Earnings -2.29M
Profit Margin -205.02%

Q3

FY25

Q4

FY25

Q1

FY26

-6M
-4M
-2M
0
-500.0%
-400.0%
-300.0%

Analyst Insights

View More

Analyst Price Targets

0.30
0.30 Average
0.0920 Current
0.30 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    30.74M

  • Enterprise Value

    34.94M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.23

  • Price/Book (mrq)

    18.69

  • Enterprise Value/Revenue

    8.56

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -118.09%

  • Return on Equity (ttm)

    -1,128.59%

  • Revenue (ttm)

    4.08M

  • Net Income Avi to Common (ttm)

    -14.49M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.19M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.74M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: